- Genor Biopharma Co. Ltd is a biopharmaceutical powerhouse focusing on developing and commercializing oncology and autoimmune drugs.
- We have successfully developed drug candidates targeting pathways with blockbuster potentials, encompassing top three oncology targets and five out of the ten bestselling drugs globally.
- We have leveraged primarily in-house capabilities in establishing a pipeline of 15 targeted drug candidates with tremendous commercialization potentials in China that cover both proven and novel biological pathways.
2020-12-28Genor Biopharma Announces Multiple IND applications of GB491 are under NMPA review
2020-11-04Genor Biopharma’s New Drug Application for GB242, its Infliximab biosimilar is under review by NMPA
2020-10-27Genor Biopharma has submitted New Drug Application for GB242, its Infliximab biosimilar to NMPA